D.A. Davidson & Co’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
VCM
VPM
D.A. Davidson & Co's BMY Position: Q1 2026 in Review
D.A. Davidson & Co increased its Bristol-Myers Squibb (BMY) stake by 2.6% in Q1 2026, buying an estimated $447K and bringing the position to 302,594 shares worth $18.4M. The position accounts for 0.11% of the portfolio, ranked #146.
D.A. Davidson & Co first reported a position in BMY in Q2 2013 and has held it in 52 quarters since. The position peaked at $23.3M in Q1 2025. 2,518 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- D.A. Davidson & Co held 302,594 shares of Bristol-Myers Squibb worth $18.4M as of Q1 2026.
- D.A. Davidson & Co bought 7,665 Bristol-Myers Squibb shares in Q1 2026, an estimated $447K.
- Bristol-Myers Squibb made up 0.11% of D.A. Davidson & Co's portfolio in Q1 2026, its #146 holding.
- D.A. Davidson & Co first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 52 quarters since.
- D.A. Davidson & Co's Bristol-Myers Squibb position peaked at $23.3M in Q1 2025.
- 2,518 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on D.A. Davidson & Co's 13F filing for Q1 2026, filed 5 May 2026.